Zhejiang Taimei Medical Technology Co (FRA:A2V) Net Income: €-5.18 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:A2V Zhejiang Taimei Medical Technology Co Ltd FRA:A2V
11 GF Score
Price €0.50
! 3 Warning Signs
View Full Analysis

What is Zhejiang Taimei Medical Technology Co Net Income?

Zhejiang Taimei Medical Technology Co FRA:A2V +0.40% 11 Net Income is €-5.18 Mil as of Dec. 2025. GuruFocus rates FRA:A2V with a GF Score™ of 11/100. The stock has 3 warning signs investors should review.

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Zhejiang Taimei Medical Technology Co's Net Income for the six months ended in Dec. 2025 was €-2.43 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2025 was €-5.18 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Zhejiang Taimei Medical Technology Co's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was €-0.00.


Zhejiang Taimei Medical Technology Co  (FRA:A2V) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Zhejiang Taimei Medical Technology Co's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Zhejiang Taimei Medical Technology Co Net Income Related Terms


Zhejiang Taimei Medical Technology Co Net Income Historical Data

* Premium members only.

The historical data trend for Zhejiang Taimei Medical Technology Co's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Taimei Medical Technology Co Net Income Chart

Zhejiang Taimei Medical Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Net Income
-66.64 -55.91 -44.54 -28.15 -5.20

Zhejiang Taimei Medical Technology Co Semi-Annual Data
Dec21 Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Net Income Get a 7-Day Free Trial 0.00 -21.91 -5.70 -2.75 -2.43
FRA:A2V
11GF Score
Zhejiang Taimei Medical Technology Co Ltd FRA:A2V
Net Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Taimei Medical Technology Co Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Zhejiang Taimei Medical Technology Co's Net Income for the fiscal year that ended in Dec. 2025 is calculated as

Net Income(A: Dec. 2025 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-6.148+0+0+0.953
=-5.20

Zhejiang Taimei Medical Technology Co's Net Income for the quarter that ended in Dec. 2025 is calculated as

Net Income(Q: Dec. 2025 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-2.594+0+0+0.164
=-2.43

Net Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-5.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Income →
What does a Net Income of €-5.18 Mil mean?
Zhejiang Taimei Medical Technology Co (FRA:A2V) has a Net Income of €-5.18 Mil as of Dec. 2025. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Zhejiang Taimei Medical Technology Co and its competitors.
Is Zhejiang Taimei Medical Technology Co's Net Income too high?
Zhejiang Taimei Medical Technology Co's current Net Income is €-5.18 Mil. Overall, Zhejiang Taimei Medical Technology Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Taimei Medical Technology Co's Net Income compare to VEEV and BTSG?
Zhejiang Taimei Medical Technology Co's Net Income of €-5.18 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income for a Healthcare Providers & Services company?
A good Net Income depends on the Healthcare Providers & Services industry context. However, Net Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income mean?
A high Net Income can signal that a stock is expensive relative to its fundamentals. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Zhejiang Taimei Medical Technology Co and its competitors. Zhejiang Taimei Medical Technology Co's current Net Income is €-5.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Taimei Medical Technology Co stock overvalued right now?
Zhejiang Taimei Medical Technology Co (FRA:A2V) has a current Net Income of €-5.18 Mil. The current Net Income is €-5.18 Mil. Zhejiang Taimei Medical Technology Co's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income calculated?
Net Income is calculated from a company's financial statements. For Zhejiang Taimei Medical Technology Co (FRA:A2V), the current Net Income is €-5.18 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zhejiang Taimei Medical Technology Co Business Description

Other Exchanges 02576:Hong Kong
Address 36 Changsheng South Road, 3rd Floor, Building 9, Smart Industry Innovation Park, Zhejiang Province, Jiaxing, CHN
Zhejiang Taimei Medical Technology Co Ltd is a digital solution provider focused on the pharmaceutical and medical device industry in China. It designs and delivers industry-specific software and digital services that facilitate research and development (R&D) and the commercialization of pharmaceuticals and medical devices. The software it offers is cloud-based, allowing users to access it from various devices at any time over the internet, without the need for software installation and maintenance on their devices. It has a geographical presence in Mainland China, the United States, Singapore, Korea, and Others.
11GF Score

Get the complete analysis for FRA:A2V

Net Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.50
Price